Kaushal, K., Thummar, V., & Mehta, P. (2026). Real-World Evaluation of Trastuzumab Emtansine Biosimilar in Early-Stage HER2-Positive Breast Cancer: Results from a Single-Center Retrospective Study in India: Real-world outcomes of T-DM1 biosimilar. Archives of Breast Cancer, 13(2), 182–189. https://doi.org/10.32768/abc.2906718345-529